You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The companies aim to identify biomarkers that can be used to diagnose early-onset Parkinson's disease, as well as track disease progression.
Synlab will make a gastrointestinal testing service that is based on Microba's gut microbiome test available to its network of doctors and clinics.
The firms are developing clinical and RUO workflows that use NGS for pathogen identification and will comarket IDbyDNA's Explify data platform.
The DNBSEQ-T7 ultra-high-throughput sequencer, metagenomic sequencing kit for coronaviruses, and 2019-nCoV RT-qPCR kit have received authorization from China's NMPA.
The University of Utah spinout said it will use the funding to enhance and expand its NGS-based Explify microbe identification platform and support its lab.
Natera discussed its cancer and transplant rejection testing businesses, while Exact Sciences explained how it will benefit from its Genomic Health acquisition.
The funding supports development of a low-cost platform for detection of antimicrobial resistance elements in complex microbial communities.
MinIon sequencing identified pathogens and antimicrobial resistance genes in the gut of preterm infants with suspected necrotizing enterocolitis.
The French metagenomic sequencing firm received funding from both historical and new investors, including debt financing from Norgine Ventures.
The team is now conducting additional studies of mNGS in plasma, as well as looking to reduce turnaround time by running the test on a nanopore sequencer.